Literature DB >> 11121388

The Delta F508 mutation shortens the biochemical half-life of plasma membrane CFTR in polarized epithelial cells.

G D Heda1, M Tanwani, C R Marino.   

Abstract

Although the biosynthetic arrest of the DeltaF508 mutant of cystic fibrosis transmembrane conductance regulator (CFTR) can be partially reversed by physical and chemical means, recent evidence suggests that the functional stability of the mutant protein after reaching the cell surface is compromised. To understand the molecular basis for this observation, the current study directly measured the half-life of Delta F508 and wild-type CFTR at the cell surface of transfected LLC-PK(1) cells. Plasma membrane CFTR expression over time was characterized biochemically and functionally in these polarized epithelial cells. Surface biotinylation, streptavidin extraction, and quantitative immunoblot analysis determined the biochemical half-life of plasma membrane DeltaF508 CFTR to be approximately 4 h, whereas the plasma membrane half-life of wild-type CFTR exceeded 48 h. This difference in biochemical stability correlated with CFTR-mediated transport function. These findings indicate that the Delta F508 mutation decreases the biochemical stability of CFTR at the cell surface. We conclude that the Delta F508 mutation triggers more rapid internalization of CFTR and/or its preferential sorting to a pathway of rapid degradation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11121388     DOI: 10.1152/ajpcell.2001.280.1.C166

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  48 in total

Review 1.  Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis.

Authors:  Marina S Gelman; Ron R Kopito
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy.

Authors:  Nadzeya V Marozkina; Sean Yemen; Molly Borowitz; Lei Liu; Melissa Plapp; Fei Sun; Rafique Islam; Petra Erdmann-Gilmore; R Reid Townsend; Cheryl F Lichti; Sneha Mantri; Phillip W Clapp; Scott H Randell; Benjamin Gaston; Khalequz Zaman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-08       Impact factor: 11.205

3.  Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.

Authors:  Xuehong Liu; Nicolette O'Donnell; Allison Landstrom; William R Skach; David C Dawson
Journal:  Biochemistry       Date:  2012-06-15       Impact factor: 3.162

4.  When is hot not so hot? Fever reduces brain inhibition.

Authors:  Richard W Olsen
Journal:  Epilepsy Curr       Date:  2006 Sep-Oct       Impact factor: 7.500

5.  Effect of rapamycin on the fate of P23H opsin associated with retinitis pigmentosa (an American Ophthalmological Society thesis).

Authors:  Shalesh Kaushal
Journal:  Trans Am Ophthalmol Soc       Date:  2006

6.  Cystic fibrosis transmembrane conductance regulator: temperature-dependent cysteine reactivity suggests different stable conformers of the conduction pathway.

Authors:  Xuehong Liu; David C Dawson
Journal:  Biochemistry       Date:  2011-11-04       Impact factor: 3.162

Review 7.  Rescuing ΔF508 CFTR with trimethylangelicin, a dual-acting corrector and potentiator.

Authors:  James F Collawn; Lianwu Fu; Rafal Bartoszewski; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-25       Impact factor: 5.464

Review 8.  Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.

Authors:  C N Belcher; N Vij
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

9.  A "SYDE" effect of hierarchical phosphorylation: possible relevance to the cystic fibrosis basic defect.

Authors:  A Venerando; L Cesaro; O Marin; A Donella-Deana; L A Pinna
Journal:  Cell Mol Life Sci       Date:  2014-02-25       Impact factor: 9.261

10.  Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator.

Authors:  Martina Gentzsch; Xiu-Bao Chang; Liying Cui; Yufeng Wu; Victor V Ozols; Amit Choudhury; Richard E Pagano; John R Riordan
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.